Italy's research-based pharmaceutical association, Farmindustria, has welcomed social research institute the Censis' publication of data concerning the risk of counterfeit medicines in the country. Although the estimated fake drug market is estimated to be only 0.1%, people are also at risk from the unsupervised on-line purchase of prescription agents, with anabolic steroids considered to be a particular problem.
Welfare Undersecretary Ferruccio Fazio, speaking at a conference organized by the Censis, announced a 60.0-million-euro ($78.8 million) program to monitor pharmacies and sports centers to evaluate the extent of prescription drug abuse in the country.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze